Meanwhile, increasing the width of the metallaligand or
pyridyl ligand hindered the formation of those highly
stable BRs and led to unoccupied MRs. Thus, these
MRs were further used in catalysis on larger substrates,
for example, the acyl-transfer reaction between
N-acetylimidazole and (4-(pyridin-4-yl)phenyl) metha-
nol.
4,4'-bipyridylacetylene (L2) (40.8 mg, 0.2 mmol) in-
stead of 4,4'-bipyridine (L1). 4a was obtained as a yel-
low solid in a 92.3% yield (246.1 mg); 1H NMR (400
MHz, CD3OD ppm): δ = 8.80 (d, J=5.6 Hz, 12H, Py-H),
8.70 (d, J=5.6 Hz, 12H, Py-H), 8.33 (d, J=8.0 Hz, 6H,
obpa-H), 8.07 (d, J=8.0 Hz, 6H, obpa-H), 7.76 (d, J=5.6
Hz, 12H, Py-H), 6.98 (d, J=5.6 Hz, 12H, Py-H), 6.78 (t,
6H, obpa-H), 6.59 (t, 6H, obpa-H), 1.79 (s, 90H, Cp*),
1.74
(s,
90H,
Cp*);
Anal.
calcd
for
Experimental
C276H252F36N24O72Pd6Rh12S12: C 41.44, H 3.18, N 4.20,
found: C 41.43, H 3.15, N 4.18; ESI-MS m/z: [4a-BRs
− 3OTf]3+ calcd. 2517.24, found 2517.24; [4a-BRs −
4OTf]4+ calcd. 1850.69, found 1850.69; IR (KBr disk,
cm−1) v = 1606, 1581, 1471, 1422, 1383, 1342, 1261,
1225, 1202, 1161, 1031, 834, 759, 639, 587, 518, 502,
461.
Preparation of 4b-BRs. The synthesis of 4b-BRs
was carried out similarly to that of 4a-BRs with the use
of Na2[Cu(opba)] (71.4 mg, 0.2 mmol) instead of
K2[Pd(opba)]. 4b was obtained as a green solid in a 90.8%
Preparation of Ⅱ-BRs. A CH3OH solution of
[Cp*RhCl2]2 (124 mg, 0.2 mmol) was added to a solu-
tion of naphthazarine (38 mg, 0.2 mmol) and NaOH (16
mg, 0.4 mmol) in CH3OH (40 mL), and the suspension
was stirred at room temperature for 6 h. AgOTf (102.8
mg, 0.4 mmol) was added to the mixture and stirred for
3 h, followed by filtration to remove insoluble com-
pounds (AgCl and NaCl). 4,4'-Bipyridylacetylene (40.8
mg, 0.2 mmol) was then added to the filtrate. After the
solution was stirred at room temperature for 12 h, the
reaction mixture was concentrated to a volume of 3 mL
under reduced pressure, filtered through Celite and re-
crystallized by slow diffusion of diethyl ether into the
filtrate. A green crystalline solid was obtained in 88.6%
yield (206.7 mg); 1H NMR (400 MHz, CD3OD, ppm): δ
= 9.04 (d, J =5.6 Hz, 24H, Py-H), 7.30 (d, J =5.6 Hz,
24H, Py-H), 6.70 (s, 24H, naphthazarine-H), 1.69 (s,
180H, Cp*); Anal. Calcd for C276H252F36N12O60Rh12S12:
C 47.35, H 3.63, N 2.40, found: C 47.31, H 3.64, N 2.43;
ESI-MS m/z: [Ⅱ-BRs − 3OTf]3+ calcd. 2184.11, found
2184.11; [Ⅱ-BRs − 4OTf]4+ calcd. 1600.84, found
1600.84; IR (KBr disk, cm−1) v = 1604, 1533, 1488,
1416, 1270, 1224, 1157, 1031, 963, 854, 836, 638, 548,
518, 445.
Preparation of 3a. A CH3OH solution of
[Cp*RhCl2]2 (124 mg, 0.2 mmol) was added to a solu-
tion of K2[Pd(opba)] (86.4 mg, 0.2 mmol) in CH3OH
(40 mL), and the suspension was stirred at room tem-
perature for 1 h. AgOTf (102.8 mg, 0.4 mmol) was then
added to the mixture, and this was stirred for 6 h fol-
lowed by filtration to remove insoluble compounds
(AgCl and NaCl). 4,4'-bipyridine (L1) (31.2 mg, 0.2
mmol) was then added to the filtrate. After the solution
was stirred at room temperature for 12 h, the reaction
mixture was concentrated to a volume of 3 mL under
reduced pressure, filtered through Celite and recrystal-
lized by slow diffusion of diethyl ether into the filtrate.
An orange crystalline solid was obtained in 91.6% yield
(235.4 mg); 1H NMR (400 MHz, CD3OD and d6-DMSO,
ppm): δ = 8.70 (d, J=6.4 Hz, 8H, Py-H), 8.21 (d, J=6.4
Hz, 8H, Py-H), 8.18 (d, J=6.0 Hz, 4H, obpa-H), 7.27 (t,
4H, obpa-H), 1.72 (s, 60H, Cp*); Anal. calcd for
C84H84F12N8O24Pd2Rh4S4: C 39.25, H 3.29, N 4.36,
found: C 39.20, H 3.27, N 4.33; IR (KBr disk, cm−1) v
=1610, 1581, 1470, 1420, 1383, 1343, 1278, 1224, 1160,
1072, 1031, 819, 759, 638, 587, 517, 462.
yield
(234.3
mg);
Anal.
calcd
for
C276H252F36N24O72Cu6Rh12S12: C 42.82, H 3.28, N 4.34,
found: C 42.81, H 3.25, N 4.31; IR (KBr disk, cm−1) v =
1608, 1576, 1461, 1412, 1384, 1348, 1261, 1225, 1202,
1168, 1035, 837, 751, 639, 587, 517, 502, 462.
Preparation of 5a-BRs. The synthesis of 5a was
carried out similarly to that of 3a with the use of
1,4-di(pyridin-4-yl)benzene (L3) (46.4 mg, 0.2 mmol)
instead of 4,4'-bipyridine (L1). 5a-BRs was obtained as
1
a yellow solid in a 93.8% yield (255.4 mg); H NMR
(400 MHz, CD3OD, ppm): δ = 9.37 (d, J=5.6 Hz, 6H,
Py-H), 9.31 (d, J=5.6 Hz, 6H, Py-H), δ = 9.02 (d, J=5.6
Hz, 6H, Py-H), 8.87 (d, J=5.6 Hz, 6H, Py-H), 8.56 (d,
J=8.0 Hz, 6H, Py-H), 8.21 (d, J=5.6 Hz, 6H, Py-H),
8.09 (d, J=8.0 Hz, 6H, obpa-H), 7.82 (d, J=8.0 Hz, 6H,
obpa-H), 7.01 (d, J=5.6 Hz, 6H, Py-H), 6.83 (br, 6H,
phenyl-H), 6.82 (d, J=8.0 Hz, 6H, Py-H), 6.81 (t, 6H,
obpa-H), 6.54 (t, 6H, obpa-H), 6.41 (br, 6H, phenyl-H),
5.22 (br, 6H, phenyl-H), 5.15 (br, 6H, phenyl-H), 1.88 (s,
90H, Cp*), 1.73 (s, 90H, Cp*); Anal. calcd for
C288H276F36N24O72Pd6Rh12S12: C 42.35, H 3.41, N 4.12,
found: C 42.36, H 3.39, N 4.15; ESI-MS m/z: [5a-BRs
− 5OTf]5+ calcd. 1484.81, found 1484.80; [5a-BRs −
6OTf]6+ calcd. 1212.01, found 1212.03; IR (KBr disk,
cm−1) v =1609, 1581, 1421, 1258, 1224, 1156, 1030,
817, 756, 638, 586, 518, 460.
Preparation of 6b. The synthesis of 6b was carried
out similarly to that of 4b-BRs with the use of
1,4-bis(4-pyridyl)naphthalene (L4) (56.4 mg, 0.2 mmol)
instead of 4,4'-bipyridylacetylene (L2). 6b was obtained
as a green solid in a 90.5% yield (247.7 mg); Anal.
calcd for C104H96Cu2F12N8O24Rh4S4: C 45.64, H 3.54, N
4.09, found: C 45.66, H 3.53, N 4.10; ESI-MS m/z: [6b
− 2OTf]2+ calcd. 1219.55, found 1219.57; [6a-BRs −
4OTf]4+ calcd. 1850.69, found 1850.69; IR (KBr disk,
cm−1) v = 1617, 1587, 1471, 1419, 1278, 1224, 1161,
1031, 638, 573, 517, 463.
Preparation of 4a-BRs. The synthesis of 4a-BRs
was carried out similarly to that of 3a with the use of
Preparation of 7a-BRs. The synthesis of 7a-BRs
This article is protected by copyright. All rights reserved.